Developer docs
API playgroundTry for free, no card

Search company profiles

Kemo Sabe

Full company profile

uuid000g3k9

Namestring
Kemo Sabe
Legal namestring
Kemo Sabe
Websiteurl
humavericks.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Kemo Sabe is a privately-held, principal-led MedTech commercialization advisory firm that helps medical technology clients identify strategic blind spots, de-risk commercialization operations, and accelerate time-to-market for new products. Its core service offering is a structured three-stage methodology — Assess, Define, Accelerate — covering strategic gap analysis, business model and product positioning validation, and tactical market acceleration including team building, funding quantification, and roadmap development. The firm targets three client types: MedTech entrepreneurs optimizing technology commercialization, intrapreneurs inside established healthcare organizations launching new products or business models, and investors performing diligence on healthcare innovation opportunities. Named public clients include Novartis Neuroscience and UNYQ, a 3D-printed custom orthopedic and prosthetic devices company.

The practice is led by Lisa Tweardy (Principal), who holds 19 patents, has published in Spine and The Journal of Neurosurgery, and previously served as CEO of Combat Medical, General Manager of Biomet Bracing, and VP/GM Spine at Ossur. Delivery capacity is supplemented by an extended bench of contributors: Eric Gorman (design sprints and innovation facilitation via Wily), Kevin Lozeau (30 years of new-product development and industrial design across consumer electronics, health, and packaged goods), and Sasha Cahill (serial MedTech entrepreneur focused on AI-enabled healthcare technology). The firm operates digitally from humavericks.com with a quote-based, project-based professional services model and direct client engagement; pricing is not publicly disclosed and no funding has been raised. Geographic footprint is stated as global with US anchoring, and there are no offices, subsidiaries, or investors disclosed in the input data.

Short descriptiontext

Kemo Sabe is a privately-held, principal-led MedTech commercialization advisory firm that helps healthcare entrepreneurs, corporate intrapreneurs, and investors de-risk and accelerate medical technology products to market via its Assess-Define-Accelerate framework.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
MedTech commercialization advisory, healthcare innovation consulting, medical device strategy, go-to-market advisory, due diligence support
Industry1 code
PRIMARYBPAHADAA
Corporate Strategy Advisory
NAICS code1 code
  • Management Consulting Services54161
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Management Consulting
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Advisory and Consulting Services
TypeProfessional Services
Description

Kemo Sabe provides strategic consulting services to MedTech companies, helping clients identify blind spots, de-risk operations, and accelerate commercialization. The firm works with entrepreneurs, intrapreneurs, and investors in the healthcare innovation ecosystem.

humavericks.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kemo Sabe is a MedTech commercialization advisory practice that helps healthcare technology companies bring products to market faster and with less risk. Using a three-stage Assess-Define-Accelerate methodology, the firm provides strategic consulting to MedTech entrepreneurs, corporate intrapreneurs, and investors evaluating healthcare innovations. The practice is led by Principal Lisa Tweardy, who brings 30+ years of MedTech experience and 19 patents in the field.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Kemo Sabe is a MedTech commercialization advisory firm offering a three-stage process framework (Assess, Define, Accelerate) to help medical technology companies bring products to market faster with reduced risk. Services target entrepreneurs developing new medical technologies, intrapreneurs within established healthcare organizations, and investors evaluating MedTech opportunities. The firm is led by Lisa Tweardy as Principal, with expertise spanning neuroscience, orthopedic and prosthetic devices, and AI-enabled healthcare technology.

Product and service1 record
1Assess Process
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kemo Sabe

Healthcare Management Consultinghumavericks.com

Kemo Sabe is a privately-held, principal-led MedTech commercialization advisory firm that helps healthcare entrepreneurs, corporate intrapreneurs, and investors de-risk and accelerate medical technology products to market via its Assess-Define-Accelerate framework.

What Kemo Sabe does

Kemo Sabe is a privately-held, principal-led MedTech commercialization advisory firm that helps medical technology clients identify strategic blind spots, de-risk commercialization operations, and accelerate time-to-market for new products. Its core service offering is a structured three-stage methodology — Assess, Define, Accelerate — covering strategic gap analysis, business model and product positioning validation, and tactical market acceleration including team building, funding quantification, and roadmap development. The firm targets three client types: MedTech entrepreneurs optimizing technology commercialization, intrapreneurs inside established healthcare organizations launching new products or business models, and investors performing diligence on healthcare innovation opportunities. Named public clients include Novartis Neuroscience and UNYQ, a 3D-printed custom orthopedic and prosthetic devices company.

The practice is led by Lisa Tweardy (Principal), who holds 19 patents, has published in Spine and The Journal of Neurosurgery, and previously served as CEO of Combat Medical, General Manager of Biomet Bracing, and VP/GM Spine at Ossur. Delivery capacity is supplemented by an extended bench of contributors: Eric Gorman (design sprints and innovation facilitation via Wily), Kevin Lozeau (30 years of new-product development and industrial design across consumer electronics, health, and packaged goods), and Sasha Cahill (serial MedTech entrepreneur focused on AI-enabled healthcare technology). The firm operates digitally from humavericks.com with a quote-based, project-based professional services model and direct client engagement; pricing is not publicly disclosed and no funding has been raised. Geographic footprint is stated as global with US anchoring, and there are no offices, subsidiaries, or investors disclosed in the input data.

Kemo Sabe firmographics

Firmographics
Name
Kemo Sabe
Legal name
Kemo Sabe
Website
https://humavericks.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Kemo Sabe is a privately-held, principal-led MedTech commercialization advisory firm that helps healthcare entrepreneurs, corporate intrapreneurs, and investors de-risk and accelerate medical technology products to market via its Assess-Define-Accelerate framework.
Ownership category
akta.pro rank

Kemo Sabe industry classification

Industry
Product category
Healthcare Management Consulting
NAICS
Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHADAA
Corporate Strategy Advisory

Keywords

  • MedTech commercialization advisory
  • Healthcare innovation consulting
  • Medical device strategy
  • Go-to-market advisory
  • Due diligence support

Kemo Sabe business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Advisory and Consulting Services: Kemo Sabe provides strategic consulting services to MedTech companies, helping clients identify blind spots, de-risk operations, and accelerate commercialization. The firm works with entrepreneurs, intrapreneurs, and investors in the healthcare innovation ecosystem.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Kemo Sabe product offering

Product offering

Core offering

Kemo Sabe is a MedTech commercialization advisory practice that helps healthcare technology companies bring products to market faster and with less risk. Using a three-stage Assess-Define-Accelerate methodology, the firm provides strategic consulting to MedTech entrepreneurs, corporate intrapreneurs, and investors evaluating healthcare innovations. The practice is led by Principal Lisa Tweardy, who brings 30+ years of MedTech experience and 19 patents in the field.

Product overview

Kemo Sabe is a MedTech commercialization advisory firm offering a three-stage process framework (Assess, Define, Accelerate) to help medical technology companies bring products to market faster with reduced risk. Services target entrepreneurs developing new medical technologies, intrapreneurs within established healthcare organizations, and investors evaluating MedTech opportunities. The firm is led by Lisa Tweardy as Principal, with expertise spanning neuroscience, orthopedic and prosthetic devices, and AI-enabled healthcare technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Assess Process

Companies that use Kemo Sabe

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Kemo Sabe technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Kemo Sabe partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights3 records

Kemo Sabe competitors and assessment

Company assessment

Market position

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

Kemo Sabe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kemo Sabe leadership team

Management profile

Number of profiles

Profiles4 records

Kemo Sabe funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kemo Sabe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kemo Sabe

What does Kemo Sabe do?

Kemo Sabe is a MedTech commercialization advisory practice that helps healthcare technology companies bring products to market faster and with less risk. Using a three-stage Assess-Define-Accelerate methodology, the firm provides strategic consulting to MedTech entrepreneurs, corporate intrapreneurs, and investors evaluating healthcare innovations. The practice is led by Principal Lisa Tweardy, who brings 30+ years of MedTech experience and 19 patents in the field.

Is Kemo Sabe a public or private company?

Kemo Sabe is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Kemo Sabe founded?

Kemo Sabe was founded in 2016. It employs 1 to 10 people.

How does Kemo Sabe make money?

One revenue line is on record: advisory and Consulting Services.

Does Kemo Sabe have an API?

No public API is recorded for Kemo Sabe.

What industry is Kemo Sabe in?

Kemo Sabe's product category is Healthcare Management Consulting. Its primary akta.pro industry code is BPAHADAA, Corporate Strategy Advisory. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales